Sodium measurement
|
phenotype |
|
Laboratory Procedure
|
53
|
69
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum gamma-glutamyl transferase measurement
|
phenotype |
|
Laboratory Procedure
|
54
|
108
|
0.100 |
None |
1.000 |
2 |
2
|
2011 |
2018 |
Mycobacterium avium-intracellulare Infection
|
disease |
Infections
|
Disease or Syndrome
|
58
|
5
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Dyskeratosis Congenita
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
146
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Gastroparesis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
95
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
CATARACT, ANTERIOR POLAR
|
disease |
Eye Diseases
|
Disease or Syndrome
|
125
|
27
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stable angina
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
144
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Infection by Cryptococcus neoformans
|
disease |
Infections
|
Disease or Syndrome
|
167
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Lyme Disease
|
disease |
Infections
|
Disease or Syndrome
|
178
|
4
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
220
|
37
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
MRSA - Methicillin resistant Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
222
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neurologic Symptoms
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
233
|
30
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Epithelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
326
|
2
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Malignant neoplasm of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
349
|
50
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Diarrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
632
|
63
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Hepatocarcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
855
|
24
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
925
|
294
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |